Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy

Pharmacology, Toxicology and Pharmaceutical Science

• Parkinson Disease 100%
• Animal 50%
• Synuclein 50%
• Synucleinopathy 50%
• Nervous System Inflammation 50%
• Diseases 25%
• Disease Exacerbation 25%
• Lewy Body 25%
• Neuroprotective Agent 25%
• Parkinsonism 25%
• Shy Drager Syndrome 25%
• Diffuse Lewy Body Disease 25%
• Cell Death 25%

Biochemistry, Genetics and Molecular Biology

• Electric Potential 50%
• Modulation 50%
• Animal 50%
• Synuclein 50%
• Cell Death 25%
• Autophagy 25%
• Protein Catabolism 25%
• Nervous System Development 25%
• Clearance 25%
• Exocytosis 25%
• Polarization 25%
• Cytoplasmic Inclusion 25%
• Nerve Fiber Transport 25%
• Protein Hydrolysis 25%

Neuroscience

• Parkinson's Disease 100%
• Synuclein 50%
• Neuroprotective Agent 25%
• Mesenchymal Stem Cell 25%
• Lewy Body 25%
• Dementia with Lewy Bodies 25%
• Neurogenesis 25%
• Proteolysis 25%
• Exocytosis 25%
• Autophagy 25%
• Brain Areas 25%
• Multiple System Atrophy 25%
• Axoplasmic Transport 25%